chartexchange

Pharming Group Q3 Prel. Revenue Rises; Tightens FY26 Revenue Guidance

RTTNews | Oct 22, 2026 2:29 AM EDT


(RTTNews) - Pharming Group N.V. (PHGUF.PK, PHGUF.OB, PHAR, PHARM.AS), a Netherlands-based biotechnology company focused on rare immune and genetic diseases, on Thursday reported increased preliminary revenue for the third quarter of fiscal 2026, driven by higher revenue from its

Read original article